Literature DB >> 26899587

Stimulant treatment history predicts frontal-striatal structural connectivity in adolescents with attention-deficit/hyperactivity disorder.

L J S Schweren1, C A Hartman2, M P Zwiers3, D J Heslenfeld4, B Franke5, J Oosterlaan4, J K Buitelaar6, P J Hoekstra2.   

Abstract

Diffusion tensor imaging (DTI) has revealed white matter abnormalities in individuals with attention-deficit/hyperactivity disorder (ADHD). Stimulant treatment may affect such abnormalities. The current study investigated associations between long-term stimulant treatment and white matter integrity within the frontal-striatal and mesolimbic pathways, in a large sample of children, adolescents and young adults with ADHD. Participants with ADHD (N=172; mean age 17, range 9-26) underwent diffusion-weighted MRI scanning, along with an age- and gendermatched group of 96 control participants. Five study-specific white matter tract masks (orbitofrontal-striatal, orbitofrontal-amygdalar, amygdalar-striatal, dorsolateral-prefrontal-striatal and medialprefrontal-striatal) were created. First we analyzed case-control differences in fractional anisotropy (FA) and mean diffusivity (MD) within each tract. Second, FA and MD in each tract was predicted from cumulative stimulant intake within the ADHD group. After correction for multiple testing, participants with ADHD showed reduced FA in the orbitofrontal-striatal pathway (p=0.010, effect size=0.269). Within the ADHD group, higher cumulative stimulant intake was associated with lower MD in the same pathway (p=0.011, effect size=-0.164), but not with FA. The association between stimulant treatment and orbitofrontal-striatal MD was of modest effect size. It fell short of significance after adding ADHD severity or ADHD type to the model (p=0.036 and p=0.094, respectively), while the effect size changed little. Our findings are compatible with stimulant treatment enhancing orbitofrontal-striatal white matter connectivity, and emphasize the importance of the orbitofrontal cortex and its connections in ADHD. Longitudinal studies including a drug-naïve baseline assessment are needed to distinguish between-subject variability in ADHD severity from treatment effects.
Copyright © 2016 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  ADHD; Diffusion tensor imaging; Long-term treatment effects; Methylphenidate; Stimulant treatment; Structural connectivity

Mesh:

Substances:

Year:  2016        PMID: 26899587     DOI: 10.1016/j.euroneuro.2016.02.007

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  7 in total

Review 1.  Toward Precision Medicine in ADHD.

Authors:  Jan Buitelaar; Sven Bölte; Daniel Brandeis; Arthur Caye; Nina Christmann; Samuele Cortese; David Coghill; Stephen V Faraone; Barbara Franke; Markus Gleitz; Corina U Greven; Sandra Kooij; Douglas Teixeira Leffa; Nanda Rommelse; Jeffrey H Newcorn; Guilherme V Polanczyk; Luis Augusto Rohde; Emily Simonoff; Mark Stein; Benedetto Vitiello; Yanki Yazgan; Michael Roesler; Manfred Doepfner; Tobias Banaschewski
Journal:  Front Behav Neurosci       Date:  2022-07-06       Impact factor: 3.617

2.  White matter integrity of the medial forebrain bundle and attention and working memory deficits following traumatic brain injury.

Authors:  Jacqueline A Owens; Gershon Spitz; Jennie L Ponsford; Alicia R Dymowski; Nicholas Ferris; Catherine Willmott
Journal:  Brain Behav       Date:  2016-12-20       Impact factor: 2.708

3.  Methylphenidate enhances neuronal differentiation and reduces proliferation concomitant to activation of Wnt signal transduction pathways.

Authors:  Edna Grünblatt; Jasmin Bartl; Susanne Walitza
Journal:  Transl Psychiatry       Date:  2018-03-01       Impact factor: 6.222

4.  Linked anatomical and functional brain alterations in children with attention-deficit/hyperactivity disorder.

Authors:  Zhao-Min Wu; Alberto Llera; Martine Hoogman; Qing-Jiu Cao; Marcel P Zwiers; Janita Bralten; Li An; Li Sun; Li Yang; Bin-Rang Yang; Yu-Feng Zang; Barbara Franke; Christian F Beckmann; Maarten Mennes; Yu-Feng Wang
Journal:  Neuroimage Clin       Date:  2019-05-04       Impact factor: 4.881

5.  Precision Medicine Care in ADHD: The Case for Neural Excitation and Inhibition.

Authors:  Ping C Mamiya; Anne B Arnett; Mark A Stein
Journal:  Brain Sci       Date:  2021-01-13

6.  Structural brain network topology underpinning ADHD and response to methylphenidate treatment.

Authors:  Kristi R Griffiths; Taylor A Braund; Michael R Kohn; Simon Clarke; Leanne M Williams; Mayuresh S Korgaonkar
Journal:  Transl Psychiatry       Date:  2021-03-02       Impact factor: 6.222

Review 7.  Sensory processing and P300 event-related potential correlates of stimulant response in children with attention-deficit/hyperactivity disorder: A critical review.

Authors:  Virginia Peisch; Tara Rutter; Carol L Wilkinson; Anne B Arnett
Journal:  Clin Neurophysiol       Date:  2021-02-05       Impact factor: 3.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.